Daiichi Sankyo-partnered anti-HER2 drug Enhertu (trastuzumab deruxtecan) has been cleared by the European Commission for use ...

Considering taking supplements to treat egfr inhibitor induced acneiform rash? Below is a list of common natural remedies used to treat or reduce the symptoms of egfr inhibitor induced acneiform rash.

The global Osimertinib drugs market is on the verge of significant expansion, with an estimated rise in revenue from US$ 4,828.6 million in 2021 to US$ 11,829.8 million by 2027. This growth reflects a ...

Vanrafia (atrasentan) is the first drug in the selective endothelin A receptor antagonist (ERA) class to be cleared in the US ...

and be considered for first-line treatment with an EGFR tyrosine kinase inhibitor if a mutation is identified.

The 216 study participants were randomized 2:1 to receive 80 mg osimertinib once daily — a third generation EGFR tyrosine kinase inhibitor — or placebo until disease progression or treatment ...

LaunXP receives exclusive development and commercialization rights for vebreltinib in combination with an EGFR inhibitor in Asia (excluding ...

New indications discovered by applying active machine learning and using samples from the company’s vast biobank of live-cell tumors ...

Creatinine is influenced by extremes of muscle mass, malnutrition, dietary intake, and drugs ... SGLT1/2 inhibitor ...

The firm believes VVD-159642 has the potential to treat a broad patient population, including those with RAS- and HER2-overexpressed tumors.